Allianz Asset Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-414
| Closed | -$323K | – | 2016 |
|
|
2021
Q1 | $323K | Buy |
+414
| New | +$323K | ﹤0.01% | 1778 |
|
|
2020
Q2 | – | Sell |
-1,163
| Closed | -$553K | – | 2058 |
|
|
2020
Q1 | $553K | Sell |
1,163
-278
| -19% | -$132K | ﹤0.01% | 1611 |
|
|
2019
Q4 | $836K | Buy |
1,441
+291
| +25% | +$169K | ﹤0.01% | 1778 |
|
|
2019
Q3 | $757K | Sell |
1,150
-1,665
| -59% | -$1.1M | ﹤0.01% | 1768 |
|
|
2019
Q2 | $2.18M | Sell |
2,815
-636
| -18% | -$492K | ﹤0.01% | 1519 |
|
|
2019
Q1 | $2.44M | Buy |
3,451
+12
| +0.3% | +$8.47K | ﹤0.01% | 1500 |
|
|
2018
Q4 | $1.61M | Buy |
3,439
+462
| +16% | +$216K | ﹤0.01% | 1529 |
|
|
2018
Q3 | $2.57M | Buy |
2,977
+256
| +9% | +$221K | ﹤0.01% | 1496 |
|
|
2018
Q2 | $1.88M | Sell |
2,721
-15
| -0.5% | -$10.3K | ﹤0.01% | 1546 |
|
|
2018
Q1 | $1.22M | Sell |
2,736
-55
| -2% | -$24.5K | ﹤0.01% | 1655 |
|
|
2017
Q4 | $1.23M | Sell |
2,791
-37
| -1% | -$16.3K | ﹤0.01% | 1672 |
|
|
2017
Q3 | $1.39M | Sell |
2,828
-6
| -0.2% | -$2.96K | ﹤0.01% | 1608 |
|
|
2017
Q2 | $1.57M | Sell |
2,834
-517
| -15% | -$286K | ﹤0.01% | 1553 |
|
|
2017
Q1 | $2.22M | Sell |
3,351
-3,884
| -54% | -$2.57M | ﹤0.01% | 1458 |
|
|
2016
Q4 | $2.42M | Sell |
7,235
-3,258
| -31% | -$1.09M | ﹤0.01% | 1414 |
|
|
2016
Q3 | $3.15M | Buy |
10,493
+486
| +5% | +$146K | ﹤0.01% | 1340 |
|
|
2016
Q2 | $1.73M | Sell |
10,007
-2,260
| -18% | -$391K | ﹤0.01% | 1490 |
|
|
2016
Q1 | $2.75M | Sell |
12,267
-56
| -0.5% | -$12.5K | ﹤0.01% | 1303 |
|
|
2015
Q4 | $7.48M | Buy |
12,323
+7,021
| +132% | +$4.26M | 0.01% | 994 |
|
|
2015
Q3 | $2.73M | Buy |
+5,302
| New | +$2.73M | ﹤0.01% | 1248 |
|